Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-29

Clinical Trial Update: Efficacy Study of Dysport® in the Treatment of Anal Fissure. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Dysport for treating anal fissure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dysport (abobotulinumtoxinA)

Snippet

Sponsor: Ipsen | Conditions: Anal Fissure | Phase 2 | Status: COMPLETED